Addex Therapeutics Ltd. (ADXN) Current Leases (2022 - 2024)

Addex Therapeutics' Current Leases history spans 3 years, with the latest figure at $8340.0 for Q4 2024.

  • For Q4 2024, Current Leases fell 97.3% year-over-year to $8340.0; the TTM value through Dec 2024 reached $8340.0, down 97.3%, while the annual FY2024 figure was $8304.7, 97.28% down from the prior year.
  • Current Leases for Q4 2024 was $8340.0 at Addex Therapeutics, down from $308845.5 in the prior quarter.
  • Across five years, Current Leases topped out at $308845.5 in Q4 2023 and bottomed at $8340.0 in Q4 2024.
  • The 3-year median for Current Leases is $296985.3 (2022), against an average of $204723.6.
  • The largest annual shift saw Current Leases increased 3.99% in 2023 before it tumbled 97.3% in 2024.
  • A 3-year view of Current Leases shows it stood at $296985.3 in 2022, then increased by 3.99% to $308845.5 in 2023, then plummeted by 97.3% to $8340.0 in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Current Leases are $8340.0 (Q4 2024), $308845.5 (Q4 2023), and $296985.3 (Q4 2022).